NCT06701461
Measurement of Osteoarthritic Patient Pain Through Electrodermal Activity Signals
StatusWithdrawn
PhaseNot applicable
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗
Stopped Withdrawn before enrolling Sponsor's reason: The study was not pursued Show 5 more changesShow less
- Enrollment target: estimated 15 to confirmed 0
- Eligibility criteria expanded, about 18 words
- Study description revised
- Site contact updated
- Publications: details revised at 2 of 2 entries
- Notable Primary completion date: Sep 2025 to Sep 2026
- Start date: Aug 2025 to Aug 2026
- Study completion date: Oct 2025 to Oct 2026
- Notable Start date: Apr 2025 to Aug 2025
- Primary completion date: May 2025 to Sep 2025
- Study completion date: Jul 2025 to Oct 2025
- Notable Start date: Jan 2025 to Apr 2025
- Primary completion date: Feb 2025 to May 2025
- Study completion date: Feb 2025 to Jul 2025
- Site contact updated
- Notable Start date: Nov 2024 to Jan 2025
- Primary and study completion dates: Jan 2025 to Feb 2025
- Study First Submitted
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
Endpoints
Primary
:Difference in pain measurements as reported by the participant via a visual analogue scale versus smartwatch reported electrodermal activity sensors
Timeframe: 40 minutes of test time, occurring all in one day.
Patient-reported pain during standardized Osteoarthritis Research Society International (OARSI) 30-second chair test
Timeframe: 5 minutes
Electrodermal activity (EDA) signals during standardized Osteoarthritis Research Society International (OARSI) 30-second chair test
Timeframe: 0 minutes. Concurrent with measurement of patient-reported pain.
Patient-reported pain during standardized Osteoarthritis Research Society International (OARSI) 40m fast-paced walk test
Timeframe: 10 minutes
Electrodermal activity (EDA) signals during standardized Osteoarthritis Research Society International (OARSI) 40m fast-paced walk test
Timeframe: 0 minutes. Concurrent with measurement of patient-reported pain.
Patient-reported pain during standardized Osteoarthritis Research Society International (OARSI) stair climb test
Timeframe: 10 minutes
Electrodermal activity (EDA) signals during standardized Osteoarthritis Research Society International (OARSI) stair climb test
Timeframe: 0 minutes. Concurrent with measurement of patient-reported pain.
Accuracy of predicting patient pain from electrodermal activity signal (EDA) during standardized Osteoarthritis Research Society International (OARSI) function tests
Timeframe: 0 minutes. Done after all data has been collected.
Percentage of correctly identified pain events (Sensitivity) as measured by the smartwatch (True positive events)
Timeframe: 0 minutes. Done after all data has been collected.
Percentage of correctly identified non-pain events (Specificity) as measured by the smartwatch (True negative non-events)
Timeframe: 0 minutes. Done after all data has been collected.
Arms and interventions
Electrodermal Activity Measurement SubjectsExperimental
Participants will have their baseline electrodermal activity (EDA) response to pain measured as well as their EDA response measured while participating in a set of standardized functional tests.
Devices: Electrodermal Activity signal
Sites
1 site in 1 country
- Dartmouth-Hitchcock Medical CenterLebanon, New Hampshire, United States